Sugi Predict

Sugi Predict / Compounds / SCHEMBL3515526

SCHEMBL3515526

SCHEMBL3515526

COCc1cc(-c2ccc3ncc4c(c3c2)n(-c2cn(C)nc2Cl)c(=O)n4C)cnc1OC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MTOR P42345 11/20 0.47
▸ PIK3CD O00329 11/20 0.47
▸ ATM Q13315 8/20 0.47
▸ ATR Q13535 7/20 0.47
▸ PIK3CB P42338 8/20 0.47
▸ PIK3CG P48736 8/20 0.47
▸ PIK3CA P42336 6/20 0.46
▸ PRKDC P78527 2/20 0.44
▸ PIK3C2A O00443 1/20 0.42
▸ PIK3C2B O00750 1/20 0.42
▸ CHEK1 O14757 1/20 0.42
▸ ABCB11 O95342 1/20 0.42
▸ CSF1R P07333 1/20 0.42
▸ MET P08581 1/20 0.42
▸ PIK3R1 P27986 1/20 0.42
▸ LTK P29376 1/20 0.42
▸ CDK7 P50613 1/20 0.42
▸ NEK2 P51955 1/20 0.42
▸ JAK3 P52333 1/20 0.42
▸ LIMK1 P53667 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3514845 0.92 MTOR (0.47) MTORPIK3CDATMATRPIK3CB
SCHEMBL3514482 0.91 MTOR (0.50) MTORPIK3CDATMATRPIK3CB
SCHEMBL3513401 0.90 ATM (0.47) MTORPIK3CDATMATRPIK3CB
SCHEMBL3518296 0.89 ATM (0.46) MTORPIK3CDATMATRPIK3CB
SCHEMBL3514200 0.88 MTOR (0.48) MTORPIK3CDATMATRPIK3CB
SCHEMBL3516570 0.87 ATM (0.49) MTORPIK3CDATMATRPIK3CB
SCHEMBL3513571 0.87 ATM (0.64) MTORPIK3CDATMATRPIK3CB
SCHEMBL3513189 0.86 MTOR (0.51) MTORPIK3CDATMATRPIK3CB
SCHEMBL3516548 0.85 PIK3CD (0.47) MTORPIK3CDATMATRPIK3CB
SCHEMBL3515488 0.85 MTOR (0.48) MTORPIK3CDATMATRPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140005163-A1 1H-IMIDAZO[4,5-C]QUINOLINONE DERIVATIVES NOVARTIS AG (CH) 2014-01-02 — — US claimed
US-20100317657-A1 1H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES NOVARTIS AG 2010-12-16 — — US claimed
US-20140005163-A1 1H-IMIDAZO[4,5-C]QUINOLINONE DERIVATIVES NOVARTIS AG (CH) 2014-01-02 — — US disclosed
US-8476294-B2 1H-imidazo[4,5-c]quinolinone derivatives NOVARTIS AG (CH) 2013-07-02 — — US disclosed
US-8476294-B2 1H-imidazo[4,5-c]quinolinone derivatives NOVARTIS AG (CH) 2013-07-02 — — US disclosed
US-8476294-B2 1H-imidazo[4,5-c]quinolinone derivatives NOVARTIS AG (CH) 2013-07-02 — — US disclosed
US-20100317657-A1 1H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES NOVARTIS AG 2010-12-16 — — US disclosed
US-20100317657-A1 1H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES NOVARTIS AG 2010-12-16 — — US disclosed
US-20100317657-A1 1H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES NOVARTIS AG 2010-12-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100317657-A1 1H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES PRKCA, CSNK1A1, ABL1 MTOR 374/4885PIK3CD 83/4885ATM 995/4885
US-20140005163-A1 1H-IMIDAZO[4,5-C]QUINOLINONE DERIVATIVES PRKCA, CSNK1A1, ABL1 MTOR 374/4885PIK3CD 83/4885ATM 995/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.